Efficacy of Romiplostim In the Treatment and Prevention of Recurrence of Persistent Chemotherapy-Induced Thrombocytopenia By Ogkologos - March 26, 2026 53 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the RECITE study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Tarlatamab Transdermal Oestradiol Patches Non-inferior to LHRH Agonists Regarding Metastasis-Free Survival in Patients with Locally Advanced Prostate Cancer EMA Recommends Extension of Indications for Selpercatinib MOST POPULAR Merging the Histologic and Molecular Data Into an Integrated Score Significantly... October 11, 2021 After Saving Thousands of Dogs, Tragedy Strikes Famed Rescue Family January 4, 2022 Air Pollution and Breast Cancer Risk – A Link That Calls... October 17, 2023 Maintenance Therapy with CC-486 Extends Survival of Adults with AML January 16, 2020 Load more HOT NEWS New on NCI’s Websites, March 2020 Patient Guide on Bone Health in Cancer Now Available Also in French Hormone Therapy for Prostate Cancer? A Genetic Test Could Help Decide The rise of the ‘long-waiter’ – why cancer waiting times are...
